| 2008 | The use of an in vitro adenosine triphosphate-based chemotherapy response assay to predict chemotherapeutic response in breast cancer | 한운섭; 성순희; 문병인 | Article |
| 2016 | The value of cytoplasmic Y-box-binding protein 1 as a prognostic marker for breast cancer in Korean | 서주영; 성순희; 문병인; 임우성; 박희정; 우주현 | Article |
| 2007 | Toxicity of concurrent adjuvant CMF chemotherapy and radiotherapy in patients with early breast cancer | 최금자; 최혜영; 문병인; 서현숙; 최국진 | Article |
| 2022 | Treatment Outcomes according to the EndoPredict Score in ER-Positive, HER2-Negative Early Breast Cancer | 문병인; 김규보; 정원근 | Article |
| 2016 | Two-year Follow-up of Volumetric-modulated Arc Therapy for Treating Internal Mammary Nodes in Locally Advanced Breast Cancer | 문병인; 이레나; 임우성; 백남선; 김규보; 이지혜 | Article |
| 2016 | Variability of Ki67 labeling index depending on different measurements in luminal type breast cancers | 문병인 | Meeting Abstract |
| 2014 | Zonal difference and prognostic significance of Foxp3 regulatory T cell infiltration in breast cancer | 구혜수; 성순희; 문병인; 조민선; 임우성; 박상희 | Article |
